In the United States, cancer is the number one disease killer of children. Yet pediatric cancer isn’t exclusive to America; it’s a global epidemic that affects more than 300,000 children around the world.
In the United States, cancer is the number one disease killer of children. Yet pediatric cancer isn’t exclusive to America; it’s a global epidemic that affects more than 300,000 children around the world.
In the United States, cancer is the number one disease killer of children. Yet pediatric cancer isn’t exclusive to America; it’s a global epidemic that affects more than 300,000 children around the world.
At Rally Foundation for Childhood Cancer Research, we often describe ourselves as “philanthropic seed investors in the next great discovery.” That’s because Rally invests early and continues to invest as projects make progress. It’s also because we like to take a few risks when it comes to funding the more “unconventional” research projects. After all, it only takes one spark to light a fire, and that spark—that next great discovery—could pave the way to finding a cure. Dr. Sam Volchenboum’s...
Chills ran up and down my arms when I opened the link that Rally-funded researcher Dr. Gregory Friedman sent. I was staring at the New England Journal of Medicine logo, an article about Dr. Friedman’s brain cancer research and an acknowledgement to Rally for our support. “As a young investigator in 2013, I received my first grant directly supporting my lab research from Rally. The support enabled us to obtain the critical preclinical data needed for FDA approval to conduct the first pediatric...
We are living in unprecedented times. As the world grapples with a number of issues, including the COVID-19 pandemic, nothing seems normal or constant—but that really isn’t true. Childhood cancer remains a constant. At Rally, every day we are hearing about new diagnoses, relapses and even kids dying from cancer. You know what else remains constant? The commitment of the Rally Foundation Board of Directors, Advisors, supporters, and staff to fund the best cutting-edge childhood cancer...
Rally Researcher, Medical Advisory Board member and pediatric oncologist Dr. Michael Kinnaman is the recipient of Rally’s Postdoctoral and Clinical Research Fellow Grant and most recently was awarded a 2020 Young Investigator Grant. In part two of this two-part series, Dr. Kinnaman reveals how our grant has helped fund his research project on characterizing osteosarcoma tumor cells that are resistant to our current therapy with the end goal of discovering new treatment strategies that are...
Rally Researcher and pediatric oncologist Dr. Michael Kinnaman received a Rally Postdoctoral and Clinical Research Fellow Grant. In part one of this two-part series, Dr. Kinnaman shares his story and why he was drawn to pediatric oncology and research. Have you ever wondered about the career path of a pediatric oncologist and clinical researcher? Dr. Kinnaman's journey began with a decision made during his sophomore year in college. Having dual passions for law and science, Dr. Kinnaman...
Could you use some good news? We have some good news. Actually, we have some GREAT news! Rally Foundation for Childhood Cancer Research just awarded $3.3 million in childhood cancer research grants. This is our largest single-year commitment and brings Rally Foundation’s awarded total to $20 million to find better treatments with fewer long-term side effects and, ultimately, cures. Thank you to our supporters who made these grants possible. Thank you to the Rally Medical Advisory Board who...